Smartleaf Asset Management LLC Increases Position in ICU Medical, Inc. (NASDAQ:ICUI)

Smartleaf Asset Management LLC lifted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 166.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 907 shares of the medical instruments supplier’s stock after buying an additional 567 shares during the quarter. Smartleaf Asset Management LLC’s holdings in ICU Medical were worth $140,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of ICUI. Barclays PLC grew its position in ICU Medical by 15.6% in the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock valued at $10,790,000 after acquiring an additional 8,010 shares during the last quarter. LMR Partners LLP purchased a new stake in shares of ICU Medical during the third quarter valued at $3,884,000. Principal Financial Group Inc. grew its holdings in shares of ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after purchasing an additional 25,031 shares during the last quarter. MetLife Investment Management LLC increased its stake in ICU Medical by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock worth $2,258,000 after buying an additional 6,981 shares during the period. Finally, Jennison Associates LLC bought a new stake in ICU Medical during the 4th quarter valued at about $556,000. 96.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on ICUI shares. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a report on Wednesday, December 11th. Finally, KeyCorp upped their target price on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $199.67.

ICU Medical Stock Down 0.9 %

ICU Medical stock opened at $142.22 on Friday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The firm has a market cap of $3.48 billion, a P/E ratio of -31.12 and a beta of 0.63. The business has a fifty day moving average of $159.57 and a two-hundred day moving average of $165.93. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26.

Insider Buying and Selling

In other news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares of the company’s stock, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 6.70% of the stock is currently owned by company insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.